MAUDE Adverse Event Report: HOYA SURGICAL OPTICS, INC. HOYA ISERT 250; INTRAOCULAR LENS

Model Number HOYA ISERT 250 (+22.50 D)

Device Problem Inaccurate Information (4051)

Patient Problem Visual Impairment (2138)

Event Date 11/26/2019

Event Type  Injury  

Manufacturer Narrative

This initial emdr is being submitted to fda for outside us like products reporting.Manufacturer's codes for patient and device have been entered.Codes for method, results and conclusion are pending completion of complaint product investigation.Once this investigation is completed, a follow-up report will be submitted to fda with the additional manufacturer's codes included.

Event Description

Complaint description: patient got myopia.Error of predicted refractive.Severe dysphotopsia.Female, white.Implant date was (b)(6) 2019.Patient impact additional information: refractive error, myopia, severe dysphotopsia, permanent or negative impact on patient health expected.Secondary surgery required on future date.

Event Description

Complaint description: patient got myopia.Error of predicted refractive.Severe dysphotopsia.Female, white.Implant date was (b)(6) 2019.Patient impact - additional information: refractive error, myopia, severe dysphotopsia, permanent or negative impact on patient health expected.Secondary surgery required on future date.

Manufacturer Narrative

This follow-up #1 emdr is being submitted to fda for outside us like products reporting.Regarding section h6 - manufacturer's codes for patient and device have been reported in the initial report.Codes for method, results and conclusion are pending completion of complaint product investigation.Once this investigation is completed, a follow-up report will be submitted to fda with the additional manufacturer's codes included.Corrected data: section g1-2: manufacturing site contact information has been corrected.Additional information: section h-9: a type 2 recall was determined to be required in iran; however, the execution is pending due to covid-19 lockdown.Capa-20-0002 was initiated for this corrective action.An additional follow-up report will be submitted to fda as new information is obtained.

Manufacturer Narrative

This follow-up #2 emdr is being submitted to fda for a reportable event that occurred outside of the usa.The report includes additional information not available/included in the initial report.The product was not returned to the manufacturer.The investigation was conducted, with the methods and results as noted below.Capa-20-0002 was opened because of this issue.The following investigative actions were taken: investigation concluded that the refractive error happened during the inspection process and the lots were mixed during manual selection and picking of inspection lots.An internal software update was done and validated to block operator from picking more than 1 lot.Each lot is identified with jig number and the lot traveler is always accompanied with the product.Effectiveness checks were implemented on the software validations lots and found to be effective.The recall was not executed due to covid-19 situation, and thus all products are blocked in iran.

Event Description

Complaint description: patient got myopia.Error of predicted refractive.Severe dysphotopsia.Female, white.Implant date was (b)(6) 2019.Patient impact: additional information: refractive error, myopia, severe dysphotopsia, permanent or negative impact on patient health expected.Secondary surgery required on future date.

Manufacturer Narrative

This follow-up #3 emdr is being submitted to fda for a reportable event that occurred outside of the usa.The report includes corrected information and additional information not available/included in the initial report.Corrected information: g1 - corrected manufacturing location.Additional information: g6 - type of report - noted as follow-up #3 h2 - type of follow-up - noted for corrected information and additional information.

Event Description

Complaint description: patient got myopia.Error of predicted refractive.Severe dysphotopsia.Female, white.Implant date was (b)(6) 2019.Patient impact - additional information: refractive error, myopia, severe dysphotopsia, permanent or negative impact on patient health expected.Secondary surgery required on future date.

• Brand Name: HOYA ISERT 250
• Type of Device: INTRAOCULAR LENS
• Manufacturer (Section D): HOYA SURGICAL OPTICS, INC.; 15335 fairfield ranch rd.; suite 250; chino hills CA 91709
• MDR Report Key: 9527270
• MDR Text Key: 178543576
• Report Number: 3006723646-2019-00109
• Device Sequence Number: 1
• Product Code: HQL
• UDI-Device Identifier: 04547480480831
• UDI-Public: 04547480480831
• Combination Product (y/n): N
• PMA/PMN Number: P080004
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: company representative,distri
• Remedial Action: Recall
• Type of Report: Initial,Followup,Followup,Followup
• Report Date: 11/27/2019

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 12/27/2019
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 05/31/2021
• Device Model Number: HOYA ISERT 250 (+22.50 D)
• Was Device Available for Evaluation?: No
• Date Manufacturer Received: 11/27/2019
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Patient Outcome(s): Other